ClinicalTrials.gov
ClinicalTrials.gov Menu

European Study of POBA Versus Cotavance(R) Paclitaxel Coated Balloon for the Treatment of Infrapopliteal Lesions in Critical Limb Ischemia (EURO CANAL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01260870
Recruitment Status : Terminated (Bayer terminated the program and sold the IP to Medronic)
First Posted : December 15, 2010
Last Update Posted : July 3, 2015
Sponsor:
Information provided by (Responsible Party):
Bayer

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : July 2013
  Actual Study Completion Date : July 2013
  Certification/Extension First Submitted : June 5, 2015